FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis

Author(s):
Davila-Fajardo, C.L.; Straaten, T. van der; Baak-Pablo, R.; Caballero, C.M.; Barrera, J.C.; Huizinga, T.W.; Guchelaar, H.J. (0000-0002-7085-1383); Swen, J.J.
Published
2015
Publication type
Article / Letter to editor
adalimumabFcGRpharmacogeneticsrheumatoid arthritissingle nucleotide polymorphismSNP
Date issued
2015-12-31
Language
English
Is part of
Pharmacogenomics (2015), Vol. 16, no. 4, p. 373-381
hdl
1887/101464
doi
10.2217/PGS.14.178